PERSONALIS INC · held by 1 fund · data as of 2026-06-03
Sector
Healthcare
Industry
Diagnostics & Research
Market cap
$1.17B
Price
$10.85
12-mo
+108.30%
Held by
1 fund
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-inform…